Zobrazeno 1 - 10
of 431
pro vyhledávání: '"Yeh CG"'
Autor:
Yeh CG; Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.; Department of Chemical Engineering, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK., Mokkawes T; Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.; Department of Chemical Engineering, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK., Bradley JM; Centre for Molecular and Structural Biochemistry, School of Chemistry, University of East Anglia, Norwich, NR4 7TJ, UK., Le Brun NE; Centre for Molecular and Structural Biochemistry, School of Chemistry, University of East Anglia, Norwich, NR4 7TJ, UK., de Visser SP; Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.; Department of Chemical Engineering, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
Publikováno v:
Chembiochem : a European journal of chemical biology [Chembiochem] 2022 Jul 05; Vol. 23 (13), pp. e202200257. Date of Electronic Publication: 2022 May 23.
Autor:
Yeh CG; Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.; Department of Chemical Engineering and Analytical Science, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK., Pierides C; Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.; Department of Chemical Engineering and Analytical Science, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK., Jameson GNL; School of Chemistry, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, 30 Flemington Road, Parkville, Vic, 3010, Australia., de Visser SP; Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.; Department of Chemical Engineering and Analytical Science, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
Publikováno v:
Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2021 Oct 01; Vol. 27 (55), pp. 13793-13806. Date of Electronic Publication: 2021 Aug 24.
Autor:
Gedefaw, Gezahagn Demsu1 (AUTHOR) gezahagndemsu68@gmail.com, Abuhay, Abere Gebru2 (AUTHOR), Endeshaw, Yaregal Semanew3 (AUTHOR), Birhan, Marta Adugna1 (AUTHOR), Ayenew, Mulugeta Endalamaw4 (AUTHOR), Genet, Geta Bayu4 (AUTHOR), Tilahun, Degalem Worku4 (AUTHOR), Mekonnen, Habtamu Sewunet5 (AUTHOR), Legesse, Bruck Tesfaye6 (AUTHOR), Daka, Dawit Tesfaye (AUTHOR), Wondie, Wubet Tazeb7 (AUTHOR), Abate, Asnake Tadesse1 (AUTHOR)
Publikováno v:
Scientific Reports. 7/17/2024, Vol. 14 Issue 1, p1-16. 16p.
Autor:
Tempero, Margaret, Ko, Andrew, Ko, AH, Shan, YS, Su, WC, Lin, YL, Dito, E, Ong, A, Wang, YW, Yeh, CG, Chen, LT
Publikováno v:
Tempero, Margaret; Ko, Andrew; Ko, AH; Shan, YS; Su, WC; Lin, YL; et al.(2013). A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/5937t6f3
Background: PEP02, also known as MM-398, is a novel nanoliposomal irinotecan that has improved pharmacokinetics and tumour bio-distribution of the free drug. This phase 2 study evaluated PEP02 monotherapy as second-line treatment for pancreatic cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::ae8c5607a9b259c5de54f0100e6801c2
http://www.escholarship.org/uc/item/5937t6f3
http://www.escholarship.org/uc/item/5937t6f3
Autor:
Li-Tzong Chen, Andrew H. Ko, Wu Chou Su, Yeh Cg, Elizabeth Dito, Yu-Lin Lin, Shan Ys, Anna Ong, Wang Yw, Margaret A. Tempero
Publikováno v:
British Journal of Cancer
Background: PEP02, also known as MM-398, is a novel nanoliposomal irinotecan that has improved pharmacokinetics and tumour bio-distribution of the free drug. This phase 2 study evaluated PEP02 monotherapy as second-line treatment for pancreatic cance
Autor:
Bäck S; Molecular Mechanisms of Cellular Stress and Inflammation Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA., Necarsulmer J; Optogenetics and Transgenic Technology Core/Genetic Engineering and Viral Vector Core, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA., Whitaker LR; Neuronal Ensembles in Drug Addiction Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD 21224, USA., Coke LM; Molecular Mechanisms of Cellular Stress and Inflammation Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA., Koivula P; Molecular Mechanisms of Cellular Stress and Inflammation Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA., Heathward EJ; Optogenetics and Transgenic Technology Core/Genetic Engineering and Viral Vector Core, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA., Fortuno LV; Optogenetics and Transgenic Technology Core/Genetic Engineering and Viral Vector Core, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA., Zhang Y; Optogenetics and Transgenic Technology Core/Genetic Engineering and Viral Vector Core, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA., Yeh CG; Neuronal Ensembles in Drug Addiction Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD 21224, USA., Baldwin HA; Molecular Mechanisms of Cellular Stress and Inflammation Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA., Spencer MD; Molecular Mechanisms of Cellular Stress and Inflammation Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA., Mejias-Aponte CA; Histology Core, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA., Pickel J; Transgenic Technology Core, Intramural Research Program, National Institute of Mental Health, Bethesda, MD 20892, USA., Hoffman AF; Electrophysiology Research Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA., Spivak CE; Electrophysiology Research Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA., Lupica CR; Electrophysiology Research Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA., Underhill SM; Laboratory of Molecular and Cellular Neurobiology, Intramural Research Program, National Institute of Mental Health, Bethesda, MD 20892, USA., Amara SG; Laboratory of Molecular and Cellular Neurobiology, Intramural Research Program, National Institute of Mental Health, Bethesda, MD 20892, USA., Domanskyi A; Institute of Biotechnology, HiLIFE, University of Helsinki, 00014 Helsinki, Finland., Anttila JE; Institute of Biotechnology, HiLIFE, University of Helsinki, 00014 Helsinki, Finland., Airavaara M; Institute of Biotechnology, HiLIFE, University of Helsinki, 00014 Helsinki, Finland., Hope BT; Neuronal Ensembles in Drug Addiction Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD 21224, USA., Hamra FK; Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Richie CT; Optogenetics and Transgenic Technology Core/Genetic Engineering and Viral Vector Core, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA., Harvey BK; Molecular Mechanisms of Cellular Stress and Inflammation Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA; Optogenetics and Transgenic Technology Core/Genetic Engineering and Viral Vector Core, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA. Electronic address: bharvey@mail.nih.gov.
Publikováno v:
Neuron [Neuron] 2019 Apr 03; Vol. 102 (1), pp. 105-119.e8. Date of Electronic Publication: 2019 Feb 18.
Publikováno v:
Clinical immunology (Orlando, Fla.). 91(1)
Primate platelets are different from rodent and rabbit platelets in that they do not express receptors for C3a or C5a or immune adherence receptors. This study assessed the effects of immune complex (IC)-induced complement activation on primate plate
Autor:
Chock VY; Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Palo Alto, CA. Electronic address: vchock@stanford.edu., Frymoyer A; Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Palo Alto, CA., Yeh CG; Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Palo Alto, CA., Van Meurs KP; Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Palo Alto, CA.
Publikováno v:
The Journal of pediatrics [J Pediatr] 2018 Sep; Vol. 200, pp. 232-239.e1. Date of Electronic Publication: 2018 Jun 01.
Autor:
Chiang NJ; National Institute of Cancer Research, National Health Research Institutes, 2F, No. 367, Sheng-Li Road, Tainan, 704, Taiwan.; Division of Hematology/Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan., Chao TY; Division of Hematology and Oncology, Taipei Medical University-Shuang Ho Hospital, Taipei, Taiwan., Hsieh RK; Division of Hematology and Oncology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan., Wang CH; Division of Hematology/Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan., Wang YW; PharmaEngine, Inc, Taipei, Taiwan., Yeh CG; PharmaEngine, Inc, Taipei, Taiwan., Chen LT; National Institute of Cancer Research, National Health Research Institutes, 2F, No. 367, Sheng-Li Road, Tainan, 704, Taiwan. leochen@nhri.og.tw.; Division of Hematology/Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan. leochen@nhri.og.tw.; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. leochen@nhri.og.tw.
Publikováno v:
BMC cancer [BMC Cancer] 2016 Nov 21; Vol. 16 (1), pp. 907. Date of Electronic Publication: 2016 Nov 21.
Autor:
Chibaudel B; Department of Medical Oncology, Franco-British Institute, Levallois-Perret, France.; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR), Paris, France.; Preclinical and Translational Cancer Research Unit, AAREC Filia Research (AFR), Paris, France., Maindrault-Gœbel F; Department of Medical Oncology, Saint-Antoine Hospital, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France., Bachet JB; Department of Gastroenterology, La Pitié-Salpetrière Hospital, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France., Louvet C; Department of Medical Oncology, Montsouris Mutualiste Institute, Paris, France., Khalil A; Department of Medical Oncology, Tenon Hospital, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France., Dupuis O; Department of Medical Oncology, Victor Hugo Clinic, Le Mans, France., Hammel P; Department of Gastroenterology, Beaujon Hospital, Assistance Publique des Hôpitaux de Paris (APHP), Clichy, France., Garcia ML; Department of Medical Oncology, Saint-Antoine Hospital, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France., Bennamoun M; Department of Medical Oncology, Montsouris Mutualiste Institute, Paris, France., Brusquant D; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR), Paris, France., Tournigand C; Department of Medical Oncology, Henri Mondor Hospital, Créteil, France., André T; Department of Medical Oncology, Saint-Antoine Hospital, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France., Arbaud C; Methodological and quality of life unit in oncology (EA3181) & Quality of life and cancer clinical research platform, CHU Besançon, Besançon, France., Larsen AK; Cancer Biology and Therapeutics, INSERM U938 and Pierre and Marie Curie University, Paris, France., Wang YW; PharmaEngine, Inc., Taipei, Taiwan., Yeh CG; PharmaEngine, Inc., Taipei, Taiwan., Bonnetain F; Methodological and quality of life unit in oncology (EA3181) & Quality of life and cancer clinical research platform, CHU Besançon, Besançon, France., de Gramont A; Department of Medical Oncology, Franco-British Institute, Levallois-Perret, France.
Publikováno v:
Cancer medicine [Cancer Med] 2016 Apr; Vol. 5 (4), pp. 676-83. Date of Electronic Publication: 2016 Jan 24.